Facts and Figures: An overview

2017 was a successful year. SFS Group generated dynamic sales growth and improved its position in the medical device industry and in the Americas, thanks to the integration of Tegra Medical. Operating profit showed double-digit growth.

Driven by strong organic growth of 7.4% and the first-time consolidation of Tegra Medical, SFS Group increased its sales in the 2017 financial year by 13.7% to CHF 1,632.7 million. All segments contributed to this pleasing development. Changes in the scope of consolidation had a positive impact of 5.8% and currency movements added 0.5% to reported sales.

Please find detailed information in the media release published on 9 March 2018.

Development of sales by segment

Gross sales
in CHF million
2017
1st half
2017
2nd half
2017 2016 ±PY
Engineered Components 428.2 497.6 925.8 768.1 20.5%
Fastening Systems 190.2 193.8 384.0 355.6 8.0%
Distribution & Logistics 160.2 162.7 322.9 312.8 3.2%
Gross sales 778.6 854.1 1,632.7 1,436.5 13.7%

Download business year 2017

Download business year 2016

Download business year 2015

Download business year 2014

Download business year 2013

Corporate Communications

SFS Group AG
Claude Stadler
Rosenbergsaustrasse 8
CH-9435 Heerbrugg
T +41 71 727 51 51